Apolipoprotein E is a ligand for triggering receptor expressed on myeloid cells 2 (TREM2)

Yuka Atagi, Chia-Chen Liu, Meghan M. Painter, Xiao Fen Chen, Christophe Verbeeck, Honghua Zheng, Xia Li, Rosa V Rademakers, Sylvia Kang, Huaxi Xu, Steven G Younkin, Pritam Das, John D. Fryer, Guojun D Bu

Research output: Contribution to journalArticle

134 Citations (Scopus)

Abstract

Several heterozygous missense mutations in the triggering receptor expressed on myeloid cells 2 (TREM2) have recently been linked to risk for a number of neurological disorders including Alzheimer disease (AD), Parkinson disease, and frontotemporal dementia. These discoveries have re-ignited interest in the role of neuroinflammation in the pathogenesis of neurodegenerative diseases. TREM2 is highly expressed in microglia, the resident immune cells of the central nervous system. Along with its adaptor protein, DAP12, TREM2 regulates inflammatory cytokine release and phagocytosis of apoptotic neurons. Here, we report apolipoprotein E (apoE) as a novel ligand for TREM2. Using a biochemical assay, we demonstrated high-affinity binding of apoE to human TREM2. The functional significance of this binding was highlighted by increased phagocytosis of apoE-bound apoptotic N2a cells by primary microglia in a manner that depends on TREM2 expression. Moreover, when the AD-associated TREM2-R47H mutant was used in biochemical assays, apoE binding was vastly reduced. Our data demonstrate that apoE-TREM2 interaction in microglia plays critical roles in modulating phagocytosis of apoE-bound apoptotic neurons and establish a critical link between two proteins whose genes are strongly linked to the risk for AD.

Original languageEnglish (US)
Pages (from-to)26043-26050
Number of pages8
JournalJournal of Biological Chemistry
Volume290
Issue number43
DOIs
StatePublished - Oct 23 2015

Fingerprint

Apolipoproteins E
Myeloid Cells
Ligands
Microglia
Phagocytosis
Alzheimer Disease
Neurons
Assays
Neurodegenerative diseases
Neurology
Low Density Lipoprotein Receptor-Related Protein-1
Frontotemporal Dementia
Proteins
Missense Mutation
Nervous System Diseases
Cell Communication
Neurodegenerative Diseases
Cytokines
Parkinson Disease
Central Nervous System

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Apolipoprotein E is a ligand for triggering receptor expressed on myeloid cells 2 (TREM2). / Atagi, Yuka; Liu, Chia-Chen; Painter, Meghan M.; Chen, Xiao Fen; Verbeeck, Christophe; Zheng, Honghua; Li, Xia; Rademakers, Rosa V; Kang, Sylvia; Xu, Huaxi; Younkin, Steven G; Das, Pritam; Fryer, John D.; Bu, Guojun D.

In: Journal of Biological Chemistry, Vol. 290, No. 43, 23.10.2015, p. 26043-26050.

Research output: Contribution to journalArticle

Atagi, Yuka ; Liu, Chia-Chen ; Painter, Meghan M. ; Chen, Xiao Fen ; Verbeeck, Christophe ; Zheng, Honghua ; Li, Xia ; Rademakers, Rosa V ; Kang, Sylvia ; Xu, Huaxi ; Younkin, Steven G ; Das, Pritam ; Fryer, John D. ; Bu, Guojun D. / Apolipoprotein E is a ligand for triggering receptor expressed on myeloid cells 2 (TREM2). In: Journal of Biological Chemistry. 2015 ; Vol. 290, No. 43. pp. 26043-26050.
@article{0d25a007a3084fae9514512d874b5000,
title = "Apolipoprotein E is a ligand for triggering receptor expressed on myeloid cells 2 (TREM2)",
abstract = "Several heterozygous missense mutations in the triggering receptor expressed on myeloid cells 2 (TREM2) have recently been linked to risk for a number of neurological disorders including Alzheimer disease (AD), Parkinson disease, and frontotemporal dementia. These discoveries have re-ignited interest in the role of neuroinflammation in the pathogenesis of neurodegenerative diseases. TREM2 is highly expressed in microglia, the resident immune cells of the central nervous system. Along with its adaptor protein, DAP12, TREM2 regulates inflammatory cytokine release and phagocytosis of apoptotic neurons. Here, we report apolipoprotein E (apoE) as a novel ligand for TREM2. Using a biochemical assay, we demonstrated high-affinity binding of apoE to human TREM2. The functional significance of this binding was highlighted by increased phagocytosis of apoE-bound apoptotic N2a cells by primary microglia in a manner that depends on TREM2 expression. Moreover, when the AD-associated TREM2-R47H mutant was used in biochemical assays, apoE binding was vastly reduced. Our data demonstrate that apoE-TREM2 interaction in microglia plays critical roles in modulating phagocytosis of apoE-bound apoptotic neurons and establish a critical link between two proteins whose genes are strongly linked to the risk for AD.",
author = "Yuka Atagi and Chia-Chen Liu and Painter, {Meghan M.} and Chen, {Xiao Fen} and Christophe Verbeeck and Honghua Zheng and Xia Li and Rademakers, {Rosa V} and Sylvia Kang and Huaxi Xu and Younkin, {Steven G} and Pritam Das and Fryer, {John D.} and Bu, {Guojun D}",
year = "2015",
month = "10",
day = "23",
doi = "10.1074/jbc.M115.679043",
language = "English (US)",
volume = "290",
pages = "26043--26050",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "43",

}

TY - JOUR

T1 - Apolipoprotein E is a ligand for triggering receptor expressed on myeloid cells 2 (TREM2)

AU - Atagi, Yuka

AU - Liu, Chia-Chen

AU - Painter, Meghan M.

AU - Chen, Xiao Fen

AU - Verbeeck, Christophe

AU - Zheng, Honghua

AU - Li, Xia

AU - Rademakers, Rosa V

AU - Kang, Sylvia

AU - Xu, Huaxi

AU - Younkin, Steven G

AU - Das, Pritam

AU - Fryer, John D.

AU - Bu, Guojun D

PY - 2015/10/23

Y1 - 2015/10/23

N2 - Several heterozygous missense mutations in the triggering receptor expressed on myeloid cells 2 (TREM2) have recently been linked to risk for a number of neurological disorders including Alzheimer disease (AD), Parkinson disease, and frontotemporal dementia. These discoveries have re-ignited interest in the role of neuroinflammation in the pathogenesis of neurodegenerative diseases. TREM2 is highly expressed in microglia, the resident immune cells of the central nervous system. Along with its adaptor protein, DAP12, TREM2 regulates inflammatory cytokine release and phagocytosis of apoptotic neurons. Here, we report apolipoprotein E (apoE) as a novel ligand for TREM2. Using a biochemical assay, we demonstrated high-affinity binding of apoE to human TREM2. The functional significance of this binding was highlighted by increased phagocytosis of apoE-bound apoptotic N2a cells by primary microglia in a manner that depends on TREM2 expression. Moreover, when the AD-associated TREM2-R47H mutant was used in biochemical assays, apoE binding was vastly reduced. Our data demonstrate that apoE-TREM2 interaction in microglia plays critical roles in modulating phagocytosis of apoE-bound apoptotic neurons and establish a critical link between two proteins whose genes are strongly linked to the risk for AD.

AB - Several heterozygous missense mutations in the triggering receptor expressed on myeloid cells 2 (TREM2) have recently been linked to risk for a number of neurological disorders including Alzheimer disease (AD), Parkinson disease, and frontotemporal dementia. These discoveries have re-ignited interest in the role of neuroinflammation in the pathogenesis of neurodegenerative diseases. TREM2 is highly expressed in microglia, the resident immune cells of the central nervous system. Along with its adaptor protein, DAP12, TREM2 regulates inflammatory cytokine release and phagocytosis of apoptotic neurons. Here, we report apolipoprotein E (apoE) as a novel ligand for TREM2. Using a biochemical assay, we demonstrated high-affinity binding of apoE to human TREM2. The functional significance of this binding was highlighted by increased phagocytosis of apoE-bound apoptotic N2a cells by primary microglia in a manner that depends on TREM2 expression. Moreover, when the AD-associated TREM2-R47H mutant was used in biochemical assays, apoE binding was vastly reduced. Our data demonstrate that apoE-TREM2 interaction in microglia plays critical roles in modulating phagocytosis of apoE-bound apoptotic neurons and establish a critical link between two proteins whose genes are strongly linked to the risk for AD.

UR - http://www.scopus.com/inward/record.url?scp=84944937240&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944937240&partnerID=8YFLogxK

U2 - 10.1074/jbc.M115.679043

DO - 10.1074/jbc.M115.679043

M3 - Article

C2 - 26374899

AN - SCOPUS:84944937240

VL - 290

SP - 26043

EP - 26050

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 43

ER -